Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Trends in Molecular Medicine|March 7, 2002
Glycogen synthase kinase 3: an emerging therapeutic targetHagit Eldar-FinkelmanExpert Opinion on Therapeutic Targets|March 22, 2006
Glycogen synthase kinase-3--a promising therapeutic target: Dr Hagit Eldar-Finkelman interviewed by Emma QuigleyHagit Eldar-FinkelmanFrontiers in Molecular Neuroscience|November 9, 2011
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSHagit Eldar-Finkelman, Ana MartinezCells|February 12, 2021
Mechanisms and Therapeutic Implications of GSK-3 in Treating NeurodegenerationIdo Rippin, Hagit Eldar-FinkelmanCommunicative & Integrative Biology|August 14, 2013
GSK-3 and lysosomes meet in Alzheimer's diseaseLimor Avrahami, Hagit Eldar-FinkelmanExpert Opinion on Therapeutic Targets|October 22, 2002
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetesOksana Kaidanovich, Hagit Eldar-FinkelmanThe Journal of Biological Chemistry|December 3, 2004
Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signalingZiva Liberman, Hagit Eldar-FinkelmanExpert Opinion on Investigational Drugs|August 29, 2003
Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatmentHagit Eldar-Finkelman, Ronit IlouzAmerican Journal of Physiology. Endocrinology and Metabolism|November 22, 2007
Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signalingHadar Sharfi, Hagit Eldar-FinkelmanCurrent Pharmaceutical Design|July 16, 2009
Peptide inhibitors targeting protein kinasesHagit Eldar-Finkelman, Miriam EisensteinPageof 6